Chapter 42: Biotechnology & Industrial Microbiology Applications
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The chapter highlights that despite significant economic disincentives in pharmaceutical development—particularly concerning antibiotics, which are losing effectiveness due to resistance—microorganisms remain the source of over two-thirds of these drugs, necessitating new discovery strategies like microbial exploration in novel habitats or using methods like reverse vaccinology for vaccine development. Industrial products range from antibiotics (like penicillin, whose fermentation yield is maximized through precise nutrient control in Penicillium chrysogenum culture), to essential food additives like amino acids (e.g., glutamate production by Corynebacterium glutamicum regulatory mutants) and organic acids, biopolymers (e.g., xanthan gum), and biosurfactants vital for remediation efforts. Culturing these microbes often involves large-scale mass culture, or “fermentation” (distinct from its physiological definition), requiring complex scale-up procedures in stirred fermenters to maximize yield, particularly for secondary metabolites like antibiotics. To achieve high industrial output, original strains are optimized using classical methods (mutagenesis, protoplast fusion) or modern targeted approaches, including heterologous gene expression, systems metabolic engineering, and directed evolution, which utilizes techniques like site-directed mutagenesis and SELEX to create new genes, proteins, or therapeutic RNA aptamers. Furthermore, the search for novel compounds is greatly expanded through metagenomics, functionally screening uncultured microbial DNA for new activities, and synthetic biology, which involves the forward engineering of biological systems to perform completely new tasks, such as producing next-generation biofuels with higher energy density than ethanol. Agricultural biotechnology relies heavily on microbial tools, including the use of the modified Ti plasmid from the plant pathogen Agrobacterium tumefaciens for genetically modifying plants, and the application of Bacillus thuringiensis (Bt) toxin as a safe, highly specific bioinsecticide. Finally, the chapter concludes by examining how microbes themselves are utilized as products, specifically in nanotechnology, leveraging precise structures like diatom shells and bacterial magnetosomes, and in the development of highly sensitive biosensors for chemical and environmental monitoring.